Literature DB >> 24797781

Substrate activity screening with kinases: discovery of small-molecule substrate-competitive c-Src inhibitors.

Meghan E Breen1, Michael E Steffey, Eric J Lachacz, Frank E Kwarcinski, Christel C Fox, Matthew B Soellner.   

Abstract

Substrate-competitive kinase inhibitors represent a promising class of kinase inhibitors, however, there is no methodology to selectively identify this type of inhibitor. Substrate activity screening was applied to tyrosine kinases. By using this methodology, the first small-molecule substrates for any protein kinase were discovered, as well as the first substrate-competitive inhibitors of c-Src with activity in both biochemical and cellular assays. Characterization of the lead inhibitor demonstrates that substrate-competitive kinase inhibitors possess unique properties, including cellular efficacy that matches biochemical potency and synergy with ATP-competitive inhibitors.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug discovery; inhibitors; kinases; medicinal chemistry; substrate activity screening

Mesh:

Substances:

Year:  2014        PMID: 24797781      PMCID: PMC4108202          DOI: 10.1002/anie.201311096

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  29 in total

Review 1.  Protein tyrosine kinases: structure, substrate specificity, and drug discovery.

Authors:  F A al-Obeidi; J J Wu; K S Lam
Journal:  Biopolymers       Date:  1998       Impact factor: 2.505

Review 2.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

3.  Metrics other than potency reveal systematic variation in responses to cancer drugs.

Authors:  Mohammad Fallahi-Sichani; Saman Honarnejad; Laura M Heiser; Joe W Gray; Peter K Sorger
Journal:  Nat Chem Biol       Date:  2013-09-08       Impact factor: 15.040

Review 4.  Tyrosine kinase inhibition: an approach to drug development.

Authors:  A Levitzki; A Gazit
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

Review 5.  Criteria for analyzing interactions between biologically active agents.

Authors:  M C Berenbaum
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

6.  Chemical influences on the specificity of tyrosine phosphorylation.

Authors:  B L Martin; D Wu; S Jakes; D J Graves
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

7.  Nonphosphorylatable tyrosine surrogates. Implications for protein kinase inhibitor design.

Authors:  J Niu; D S Lawrence
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

8.  A rationale for the design of an inhibitor of tyrosyl kinase.

Authors:  C J Yuan; S Jakes; S Elliott; D J Graves
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

Review 9.  The hunting of the Src.

Authors:  G S Martin
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

10.  Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation.

Authors:  J H Hanke; J P Gardner; R L Dow; P S Changelian; W H Brissette; E J Weringer; B A Pollok; P A Connelly
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

View more
  7 in total

1.  Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration.

Authors:  Frank E Kwarcinski; Michael E Steffey; Christel C Fox; Matthew B Soellner
Journal:  ACS Med Chem Lett       Date:  2015-07-13       Impact factor: 4.345

2.  Fluorogenic structure activity library pinpoints molecular variations in substrate specificity of structurally homologous esterases.

Authors:  Alex White; Andrew Koelper; Arielle Russell; Erik M Larsen; Charles Kim; Luke D Lavis; Geoffrey C Hoops; R Jeremy Johnson
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

3.  Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method.

Authors:  Haya Jamali; Hasan A Khan; Joseph R Stringer; Somenath Chowdhury; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2015-03-05       Impact factor: 15.419

4.  Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.

Authors:  Frank E Kwarcinski; Kristoffer R Brandvold; Sameer Phadke; Omar M Beleh; Taylor K Johnson; Jennifer L Meagher; Markus A Seeliger; Jeanne A Stuckey; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2016-03-01       Impact factor: 5.100

5.  Exquisitely specific bisubstrate inhibitors of c-Src kinase.

Authors:  Kristoffer R Brandvold; Shana M Santos; Meghan E Breen; Eric J Lachacz; Michael E Steffey; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2015-03-31       Impact factor: 5.100

Review 6.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

Review 7.  Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.

Authors:  Meghan E Breen; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2014-12-23       Impact factor: 5.100

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.